| 0% | No more than topical therapy required over the past 12-month period and at least one of the following: Characteristic lesions involving less than 5 percent of the entire body affected; or Characteristic lesions involving less than 5 percent of exposed areas affected. | You needed no more than topical therapy over the past 12-month period, AND characteristic lesions cover less than 5 percent of your entire body or less than 5 percent of exposed areas. Both halves have to be true. If you were on systemic therapy at any point in the past 12 months you are not at 0 percent even with very little skin involved — the therapy route reaches 10 percent on its own. DC 7806 is evaluated under the General Rating Formula for the Skin, and that formula prints this 0 percent level directly: no monthly payment, but the condition is on record and a later increase runs from it. The lowest compensable level under this formula is 10 percent. |
|---|
What supports this level- Characteristic lesions measured at less than 5 percent of the entire body affected
- Less than 5 percent of exposed areas affected
- Topical therapy only over the past 12-month period, with no oral antibiotics or other systemic therapy
- Chronic folliculitis diagnosis confirmed, with the location of lesions documented
- A dated record of the condition so that a later increase claim has a starting point
|
| 10% | Evaluate under the General Rating Formula for the Skin. At least one of the following: Characteristic lesions involving at least 5 percent, but less than 20 percent, of the entire body affected; or At least 5 percent, but less than 20 percent, of exposed areas affected; or Intermittent systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12-month period. | Characteristic lesions cover at least 5 percent but less than 20 percent of your entire body, or at least 5 percent but less than 20 percent of exposed areas, or you needed intermittent systemic therapy for a total of less than 6 weeks over the past 12-month period. Any one of these on its own is enough. Systemic therapy is not only corticosteroids — the formula also names phototherapy, retinoids, biologics, photochemotherapy and psoralen with long-wave ultraviolet-A light (PUVA), and the list reads “including, but not limited to,” so a systemic drug outside it still counts. |
|---|
What supports this level- Body surface area measured at 5 percent to less than 20 percent of the entire body affected
- 5 percent to less than 20 percent of exposed areas affected
- Treatment records adding up to a total of less than 6 weeks of intermittent systemic therapy over the past 12-month period — corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs
- Recurrent outbreaks documented in treatment records with dates
- Dated photographs of infected hair follicles
|
| 30% | Evaluate under the General Rating Formula for the Skin. At least one of the following: Characteristic lesions involving 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected; or Systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, over the past 12-month period. | Characteristic lesions cover 20 to 40 percent of your entire body or 20 to 40 percent of exposed areas, or you needed systemic therapy — corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs — for a total of 6 weeks or more, but not constantly, over the past 12-month period. Either one on its own is enough. Note that 40 percent exactly falls in this band; the 60 percent level asks for MORE than 40 percent. |
|---|
What supports this level- Body surface area measured at 20 to 40 percent of the entire body or of exposed areas affected
- Treatment records adding up to a total of 6 weeks or more of systemic therapy over the past 12-month period, but not constant
- Prescription or treatment records naming the therapy — corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs — with start and stop dates
- Culture results identifying the organism, with multiple body areas involved
- Dermatology specialist treatment notes
|
| 60% | Evaluate under the General Rating Formula for the Skin. At least one of the following: Characteristic lesions involving more than 40 percent of the entire body or more than 40 percent of exposed areas affected; or Constant or near-constant systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, psoralen with long-wave ultraviolet-A light (PUVA), or other immunosuppressive drugs required over the past 12-month period. | Characteristic lesions cover more than 40 percent of your entire body or more than 40 percent of exposed areas, or you needed constant or near-constant systemic therapy — corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs — over the past 12-month period. This is the highest level the General Rating Formula for the Skin provides. |
|---|
What supports this level- Body surface area measured at more than 40 percent of the entire body, or more than 40 percent of exposed areas affected
- Records showing constant or near-constant systemic therapy across the past 12-month period
- Continuous prescription history — corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs — with no meaningful gap
- Widespread follicular pustules and scarring documented
|